Clinical Practice Guidelines
2.0.0 - STU2 International flag

This page is part of the Clinical Guidelines (v2.0.0: STU2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

PlanDefinition: CHF LASIX Recommendation (Experimental)

Official URL: http://hl7.org/fhir/uv/cpg/PlanDefinition/chf-lasix Version: 2.0.0
Active as of 2024-11-26 Computable Name: CHFLASIX
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.34.30

Administer LASIX IV, transition to PO as appropriate

Generated Narrative: PlanDefinition chf-lasix

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

CPG Part Of Extension: CHFHypervolemia

CPG Enabled Extension: true

url: PlanDefinition CHFLASIX

identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.34.30

version: 2.0.0

name: CHFLASIX

type: ECA Rule

status: Active

experimental: true

date: 2024-11-26 17:38:52+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Administer LASIX IV, transition to PO as appropriate

jurisdiction: World

Goals

-DescriptionStart
*Transition to LASIX POAdmission to hospital

action

id

lasix-iv

title: LASIX IV

description: Administer LASIX IV

code: Dispense Medications

condition

kind: Stop

Expressions

-LanguageExpression
*text/cql-identifierShould Stop LASIX IV

definition: CHFLASIXIV

action

id

lasix-po

title: LASIX PO

description: Administer LASIX PO

code: Dispense Medications

condition

kind: Start

Expressions

-LanguageExpression
*text/cql-identifierShould Start LASIX PO

definition: CHFLASIXPO